Enveric Biosciences, Inc. (ENVB)

Enveric Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.36	2.29	17.72	17.36	1.58	0.04
Cash & Cash Equivalents	6.36	2.29	17.72	17.36	1.58	0.04
Cash Growth	-49.40%	-87.09%	2.12%	999.55%	3510.88%	-96.81%
Other Current Assets	1.87	1.29	0.71	0.38	0.7	0.07
Total Current Assets	8.23	3.58	18.43	17.74	2.28	0.11
Property, Plant & Equipment	0.45	0.51	0.74	0.47	0	0
Goodwill and Intangibles	0.17	0.21	0.38	8.51	1.82	0
Total Long-Term Assets	0.62	0.72	1.12	8.98	1.82	0
Total Assets	8.85	4.3	19.55	26.72	4.1	0.11
Accounts Payable	1.85	1.22	0.46	0.68	0.68	1.16
Current Debt	0	0	0.06	0.11	0	0.74
Other Current Liabilities	0.52	1.12	3.47	1.95	0	0.02
Total Current Liabilities	2.37	2.34	4	2.74	0.68	1.92
Long-Term Debt	0	0	0	0.07	0	0
Other Long-Term Liabilities	0	0	0.89	1.61	0	0
Total Long-Term Liabilities	0	0	0.89	1.68	0	0
Total Liabilities	2.37	2.34	4.88	4.41	0.68	1.92
Total Debt	0	0	0.06	0.18	0	0.74
Debt Growth	-	-	-63.80%	-	-	-85.78%
Retained Earnings	-98.96	-96.5	-79.21	-60.74	-11.76	-4.89
Comprehensive Income	-0.55	-0.57	-0.54	-0.03	-0.18	-0.01
Shareholders' Equity	6.48	1.96	14.67	22.31	3.42	-1.81
Net Cash / Debt	6.36	2.29	17.66	17.18	1.58	-0.7
Net Cash / Debt Growth	-49.25%	-87.04%	2.80%	988.38%	-	-
Net Cash Per Share	1.59	1.06	12.21	36.37	13.72	-6.59
Working Capital	5.86	1.24	14.44	15	1.6	-1.81
Book Value Per Share	1.62	0.91	10.15	47.22	29.68	-17.13

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).